Ikena Oncology, Inc.IKNANASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank43
3Y CAGR-68.2%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
-68.2%/yr
Annual compound
Percentile
P43
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineElevated
PeriodValueYoY Change
20250.25-96.7%
20247.54+29.8%
20235.81-26.1%
20227.86-69.8%
202126.04+149.0%
2020-53.16+76.3%
2019-223.99+25.4%
2018-300.32-